Rafael Christophe da Rocha Freire

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Medicina

Departamento:

Departamento de Psiquiatria e Medicina Legal/FM

ORCID:

https://orcid.org/0000-0003-3875-4601


Formação:

  • Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2013 - 2014

  • Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro

    Psiquiatria | Doutorado | 2008 - 2012

  • Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro

    Psiquiatria | Mestrado | 2007 - 2008

  • Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro

    | Especialização - Residência medica | 2004 - 2006

  • Universidade Federal do Rio de Janeiro

    Medicina | Graduação | 1997 - 2002

  • Colégio Santo Agostinho

    | Ensino Médio (2o grau) | 1994 - 1996
Laboratórios:
Nuvens de Palavras:
Artigos:

(88.89% artigos com DOI)

Titulo DOI Ano
Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review 10.2174/17450179-v19-230823-2023-4 2023
Is it possible to prevent relapse in panic disorder? 10.1080/14737175.2023.2229955 2023
An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol 10.1371/journal.pone.0269772 2022
Understanding and addressing COVID-19 vaccine hesitancy in low and middle income countries and in people with severe mental illness: Overview and recommendations for Latin America and the Caribbean 10.3389/fpsyt.2022.910410 2022
The Implications of the Diving Response in Reducing Panic Symptoms 10.3389/fpsyt.2021.784884 2021
Heart rate variability: A biomarker of selective response to mindfulness-based treatment versus fluoxetine in generalized anxiety disorder 10.1016/j.jad.2021.08.121 2021
Should systematic reviews and meta-analysis include data from preprints? 10.47626/2237-6089-2021-0324 2021
Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls 10.3389/fpsyt.2021.662963 2021
Clinical effectiveness of non-TMS neurostimulation in depression: Clinical trials from 2010 to 2020 10.1016/j.pnpbp.2021.110287 2021
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options 10.1176/appi.focus.19203 2021
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options 10.3389/fpsyt.2020.595584 2020
COVID-19 and its psychological consequences: Beware of the respiratory subtype of panic disorder 10.1016/j.resp.2020.103530 2020
Panic disorder respiratory subtype: psychopathology and challenge tests - an update 10.1590/1516-4446-2019-0717 2020
Three insights on psychoneuroimmunology of mood disorders to be taken from the COVID-19 pandemic 10.1016/j.bbih.2020.100076 2020
Features shared between fear of missing out on rewarding experiences (FOMO) and internet gaming disorder 10.1590/1516-4446-2020-0019 2020
Using the Online Psychotherapy Tool to Address Mental Health Problems in the Context of the COVID-19 Pandemic: Protocol for an Electronically Delivered Cognitive Behavioral Therapy Program 10.2196/24913 2020
Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018 10.30773/pi.2018.12.21.1 2019
The Master of Psychopharmacology: an inspiration for future generations - Donald F. Klein (1928-2019) 10.1590/1516-4446-2019-4112 2019
Panic Disorder and Chronic Caffeine Use: A Case-control Study 10.2174/1745017901915010120 2019
Panic attack provocation in panic disorder patients with a computer simulation 10.1016/j.jad.2019.11.081 2019
Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency 10.1177/0269881119878171 2019
Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment 10.1177/0269881119859372 2019
Megacities, migration and an evolutionary approach to bipolar disorder: a study of Sardinian immigrants in Latin America 10.1590/1516-4446-2018-0338 2019
Elevated peripheral kynurenine/tryptophan ratio predicts poor short-term auditory memory in panic disorder patients 10.1016/j.jpsychires.2019.03.027 2019
Negative Affect Mediates Impulsivity in Generalized Anxiety Disorder 10.1159/000503395 2019
Quality of life in panic disorder: the influence of clinical features and personality traits 10.1590/2237-6089-2019-0008 2019
Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines 10.1080/14740338.2018.1429403 2018
Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients 10.1016/j.psychres.2018.02.013 2018
Neuroimaging findings as predictors of treatment outcome of psychotherapy in anxiety disorders 10.1016/j.pnpbp.2018.04.001 2018
International Task Force on Benzodiazepines 10.1159/000489538 2018
The Prescription of Benzodiazepines for Panic Disorder 10.1097/jcp.0000000000000908 2018
The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life 10.1177/0020764018795211 2018
The role of acid-sensitive ion channels in panic disorder: a systematic review of animal studies and meta-analysis of human studies 10.1038/s41398-018-0238-z 2018
Personality Traits in Panic Disorder Patients With and Without Comorbidities 10.1097/nmd.0000000000000745 2017
The Role of Innate Immune System Receptors in Epilepsy Research 10.2174/1871527316666170725145549 2017
A 6-Year Posttreatment Follow-up of Panic Disorder Patients 10.1097/jcp.0000000000000740 2017
Predictors of Pharmacotherapy Response in Generalized Anxiety Disorder 10.1097/hrp.0000000000000127 2017
How high level of anxiety in Panic Disorder can interfere in working memory? A computer simulation and electrophysiological investigation 10.1016/j.jpsychires.2017.08.021 2017
Agomelatine in Panic Disorder 10.1097/JCP.0000000000000524 2016
Comments on -Heart rate and respiratory response to doxapram in patients with panic disorder- 10.1016/j.psychres.2016.03.002 2016
Outcome of naturalistic pharmacological treatment in panic disorder patients with the respiratory subtype 2016
High relapse rate after efficacious ultra-long term treatment of panic disorder with clonazepam or paroxetine 2016
Respiratory panic disorder in acute clonazepam treatment and long-term follow-up 10.1016/j.eurpsy.2016.01.1125 2016
The effects of regular physical activity on anxiety symptoms in healthy older adults: a systematic review 10.1590/1516-4446-2015-1893 2016
A forensic-psychiatric study of sexual offenders in Rio de Janeiro, Brazil 10.1016/j.jflm.2015.01.003 2015
Frontal cortex absolute beta power measurement in Panic Disorder with Agoraphobia patients 10.1016/j.jad.2015.05.055 2015
Treatment-resistant panic disorder: a systematic review 10.1517/14656566.2016.1109628 2015
Laboratory, Clinical and Therapeutic Features of Respiratory Panic Disorder Subtype 10.2174/1871527314666150430163142 2015
P.4.d.001 A schedule for tapering out clonazepam in panic disorder patients after long-term treatment 10.1016/S0924-977X(15)30794-X 2015
Current Pharmacological Interventions in Panic Disorder 10.2174/1871527313666140612125028 2014
The Stability of Personality Traits Despite Naturalistic Treatment for Panic Disorder 2014
A systematic review of fMRI studies in generalized anxiety disorder: Evaluating its neural and cognitive basis 10.1016/j.jad.2014.06.041 2014
Ultra-long-term outcome of panic disorder with clonazepam or paroxetine: A randomized, open, systematic treatment for 3 years and a follow-up for 6 years after 2014
Demographics, clinical characteristics and quality of life of Brazilian women with driving phobia 10.1016/j.comppsych.2013.08.003 2013
A hundred-year of Karl Jaspers' General Psychopathology (Allgemeine Psychopathologie) - 1913-2013: a pivotal book in the history of Psychiatry 10.1590/0004-282x20130068 2013
Alpha absolute power measurement in panic disorder with agoraphobia patients 10.1016/j.jad.2013.06.002 2013
Are patients with panic disorder respiratory subtype more vulnerable to tobacco, alcohol or illicit drug use? 10.1590/s0101-60832013000400002 2013
The quest for better diagnosis: DSM-5 or RDoC? 10.1590/1516-4446-2012-3501 2013
The Panic Disorder Respiratory Ratio: A Dimensional Approach to the Respiratory Subtype 10.1016/j.rbp.2012.02.008 2013
Clonazepam for the Treatment of Panic Disorder 10.2174/1389450111314030007 2013
Postural balance in patients with social anxiety disorder 10.1590/S0100-879X2011007500155 2012
Panic disorder and the respiratory system: clinical subtype and challenge tests 10.1590/S1516-44462012000500004 2012
A Randomized, Naturalistic, Parallel-Group Study for the Long-Term Treatment of Panic Disorder With Clonazepam or Paroxetine 10.1097/JCP.0b013e31823fe4bd 2012
The somatic marker affecting decisional processes in obsessive-compulsive disorder 10.1080/13546805.2011.614152 2012
Transtorno do pânico e agorafobia 2012
Sulpiride and refractory panic disorder 10.1007/s00213-012-2818-6 2012
Efficacy of a specific model for cognitive-behavioral therapy among panic disorder patients with agoraphobia: a randomized clinical trial 10.1590/S1516-31802011000500008 2011
The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study 10.1590/S1516-44462011000200009 2011
Randomized, Open Naturalistic, Acute Treatment of Panic Disorder With Clonazepam or Paroxetine 10.1097/JCP.0b013e318210b4ee 2011
Update on pharmacological treatment of panic disorder 2011
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine 10.1590/s0100-879x2011007500020 2011
New treatment options for panic disorder: clinical trials from 2000 to 2010 10.1517/14656566.2011.562200 2011
Virtual reality as a mechanism for exposure therapy 10.1080/15622970802575985 2010
Carbon dioxide-induced panic attacks and quantitative electroencephalogram in panic disorder patients 10.3109/15622970903144012 2010
Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder 10.1016/j.psychres.2008.06.025 2010
Tapering Clonazepam in Patients With Panic Disorder After at Least 3 Years of Treatment 10.1097/JCP.0b013e3181dcb2f3 2010
Comportamento violento, gênero e psicopatologia 10.1590/s1415-47142010000200006 2010
Panic Disorder Respiratory Subtype: Psychopathology, Laboratory Challenge Tests, and Response to Treatment 10.3109/10673229.2010.493744 2010
Anxiogenic properties of a computer simulation for panic disorder with agoraphobia 10.1016/j.jad.2009.12.031 2010
Use of the hospital anxiety and depression scale (HADS) in a cardiaciac emergency room ? chest pain unit 10.1590/S1807-59322009000300011 2009
Panic disorder and control of breathing 10.1016/j.resp.2008.07.011 2009
Freezing reaction in panic disorder patients associated with anticipatory anxiety 10.1002/da.20593 2009
Panic disorder and social anxiety disorder subtypes in a caffeine challenge test 10.1016/j.psychres.2008.06.023 2009
Subtipos respiratório e não respiratório do transtorno de pânico: Comparações clínicas e de qualidade de vida 2009
Antipanic drugs and pulmonary function in panic disorder patients 10.1590/s0101-60832009000400002 2009
Respiratory manifestations of panic disorder: causes, consequences and therapeutic implications 10.1590/s1806-37132009000700012 2009
Demographic and clinical features of panic disorder comorbid with bipolar I disorder: A 3-year retrospective study 10.1016/j.jad.2007.05.026 2008
A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls 10.1002/da.20354 2008
Panic disorder respiratory subtype: a comparison between responses to hyperventilation and CO2 challenge tests 10.1016/j.psychres.2007.07.015 2008
Equivalência semântica da versão brasileira da Social Avoidance and Distress Scale (SADS) 2008
The Use of Benzodiazepines in a Primary Outpatient Care Unit: The Impact of Anxiety Disorders and Depression 2008
Anxiety and depressive disorders in outpatient clinics 2008
Realidade virtual no tratamento do transtorno de pânico 10.1590/s0047-20852008000100012 2008
Personality traits spectrum in panic disorder and major depression 10.1590/s1516-44462006005000009 2007
Clinical features of respiratory and nocturnal panic disorder subtypes 10.1016/j.psychres.2006.01.003 2007
Caffeine challenge test in panic disorder and depression with panic attacks 10.1016/j.comppsych.2006.12.001 2007
Caffeine and 35% carbon dioxide challenge tests in panic disorder 10.1002/hup.840 2007
O tabagismo e o transtorno do pânico: gravidade e comorbidades 10.1590/s0101-81082007000300007 2007
35% carbon dioxide and breath-holding challenge tests in panic disorder: a comparison with spontaneous panic attacks 10.1002/da.20165 2006
The relationship between the severity of asthma and comorbidites with anxiety and depressive disorders 10.1590/S1516-44462006005000005 2006
Comparison between hyperventilation and breath-holding in panic disorder: Patients responsive and non-responsive to both tests 10.1016/j.psychres.2005.07.032 2006
Psychopathological profile of 35% CO2 challenge test-induced panic attacks: a comparison with spontaneous panic attacks 10.1016/j.comppsych.2005.07.007 2006
Do social anxiety disorder patients belong to a bipolar spectrum subgroup? 10.1016/j.jad.2004.12.007 2005
A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam 10.1016/j.psychres.2005.05.011 2005
Demographic and clinical features of schizoaffective (schizobipolar) disorder: a 5-year retrospective study. Support for a bipolar spectrum disorder. 10.1016/j.jad.2005.08.009 2005
Diurnal panic attacks with and without nocturnal panic attacks: are there some phenomenological differences? 10.1590/S1516-44462005000300010 2005
Responses to the CO2 inhalation test in social phobia and panic disorder patients 2004
Prognóstico da Doença Pré-invasiva do Colo de Uterino de Mulheres Infectadas pelo HIV - Evidências extraídas da literatura médica e discussâo quanto à efetividade do seu tratamento 2003
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Outcome of naturalistic pharmacological treatment in panic disorder patients with the respiratory subtype 2017
Panic Attacks Induced by a Computer Simulation in Patients With Panic Disorder and Agoraphobia 2017
Interferência da agorafobia na clínica e no tratamento do transtorno de panico 2017
Confiabilidade entre examinadores na escala CGI-S tradicional e sua versão ancorada no transtorno do panico 2017
Interferência da agorafobia na clínica e no tratamento do transtorno de pânico 2017
Ataques de pânico provocados por ambiente virtual 2017
Outcome of naturalistic pharmacological treatment in panic disorder patients with the respiratory subtype 2016
High relapse rate after efficacious ultra-long term treatment of panic disorder with clonazepam or paroxetine 2016
Propriedades psicometricas da versão brasileira do inventário de cinco grandes fatores em estudantes de medicina 2016
Consumo moderado de cafeína pode ser benéfico para pacientes com depressão maior? 2016
Tratamento farmacológico da transtorno de panico 2016
Avaliação do potencial ansiogenico de uma simulação de realidade virtual 2016
Contribuições do design para o uso de realidade virtual no tratamento da síndrome do pânico 2015
Associação entre neuroticismo, depressão e abuso de psicotrópicos em estudantes de medicina 2015
Transtorno de pânico: um estudo prospectivo comparativo de evolução clínica dos subtipos respiratório e não-respiratório 2015
Associação entre neuroticismo, depressão e abuso de psicotrópicos em estudantes de medicina 2015
Transtorno de pânico: um estudo prospectivo comparativo de evolução clínica dos subtipos respiratório e não-respiratório 2015
Transtorno de ansiedade generalizada - tratamento farmacológico 2015
Os pacientes com o subtipo respiratório do transtorno de pânico fazem mais uso de tabaco, álcool e substância ilícitas? 2014
Neuroticism predicts comorbidity in panic disorder patients 2014
Avaliação do Potencial Ansiogênico de uma Simulação de Realidade Virtual 2014
Análise comparativa entre pacientes portadores de transtorno do pânico que abandonaram e que não abandonaram o tratamento em ambulatório especializado para ansiedade e depressão 2014
O papel do eixo hipotálamo-pituitária-adrenal e do DHEA no transtorno do pânico 2014
Fisiopatologia, tratamento e comorbidades do transtorno de ansiedade generalizada 2014
O tratamento farmacológico do transtorno de pânico refratário 2014
Avaliação do Potencial Ansiogênico de uma Simulação de Realidade Virtual 2014
Análise comparativa entre pacientes portadores de transtorno do pânico que abandonaram e que não abandonaram o tratamento em ambulatório especializado para ansiedade e depressão 2014
A sensibilidade ao dióxido de carbono e o subtipo respiratório no transtorno de pânico 2013
Transtorno de pânico e agorafobia 2013
Pharmacotherapy of panic disorder: tapering out clonazepam and paroxetine after three years of treatment 2012
Uso de álcool, tabaco e outras substâncias em pacientes com o subtipo respiratório do transtorno de pânico 2012
A fisiopatologia do transtorno de pânico e suas correlações com o sistema respiratório 2012
Atualizações no tratamento farmacológico do transtorno do pânico: ensaios clínicos entre 2000 e 2011 2011
Treatment of the acute phase of panic disorder: an eight-week randomised, naturalistic trial with clonazepam and paroxetine 2011
Anxiogenic properties of a virtual reality simulation for panic disorder with agoraphobia 2010
O uso de ambientes virtuais no transtorno do pânico com agorafobia: um estudo piloto 2009
Manifestações respiratórias do transtorno de pânico: causas, conseqüências e implicações terapêuticas 2009
Estudo psiquiátrico-forense de uma amostra de mulheres homicidas 2009
Long-term treatment of panic disorder with clonazepam or paroxetine: a randomized naturalistic open study 2009
Comportamento Homicida em Mulheres Psicóticas 2009
A estabilidade dos traços de personalidade no transtorno do pânico 2008
Panic Disorder Respiratory Subtype: A Comparison Between Responses to Hyperventilation and CO2 Challenge Tests 2007
Does smoking increase the gravity of panic disorder? 2007
Panic attacks induced by caffeine in panic disorder and depression with panic attacks 2007
O subtipo respiratório do transtorno do pânico: uma comparação entre as respostas aos testes de hiperventilação e de inalação de CO2 a 35% 2007
O tabagismo e a gravidade do transtorno do pânico 2007
Panic disorder with social anxiety disorder comorbidity: difference of response to low versus high doses of clonazepam 2007
Transtorno De Pânico eTontura Persistente: Revisão da Literatura. 2006
Transtorno De Pânico: Ressonância Magnética Funcional (RMf) Demonstrando Hiperativação do Giro do Cíngulo Anterior e Cisto Aracnóideo 2006
Panic Disorder Associated with Severe Dizziness: demographic and clinical features and treatment with clonazepam. 2006
A five-year retrospective study in schizobipolar disorder outpatients 2006
Clinical features of 35% carbon dioxide challenge test in panic disorder: a comparison with spontaneous panic attacks 2006
Panic Disorder Subtypes and the Prevalence of Agoraphobia and Depressive Episodes 2005
Anxiety and Depressive Disorders in Asthmatic Outpatients 2005
35 Percent CO2 Challenge Test: Increase in Anxiety in Patients with Social Anxiety Disorder 2005
Respiratory Panic Disorder in a Long-Term Clonazepan Follow-up 2005
Subtipos de transtorno do pânico e prevalência de episódios prévios de depressão e agorafobia 2005
Teste de inalação de CO2 a 35% - aumento da ansiedade em pacientes com transtorno de ansiedade social 2005
The Role of Personality Traits in Anxiety and Depressive Disorders 2004
Os Traços de Personalidade na Depressão e nos Transtornos de Ansiedade 2004
Ataques de Pânico Laboratoriais e Eletroencefalograma Quantitativo: um Paradigma para uma Amostra de Transtorno do Pânico Tratada com Gabapentina 2004
Social Phobia and Panic Disorder: Responses to the Carbon Dioxide Challenge Test 2004
Fobia Social e Transtorno do Pânico - Resposta ao teste de inalação de CO2 2004
Depressão e Ansiedade em Pacientes com Asma 2004
Executive abnormal function in panic disorder 2004
Carbon dioxide test and clonazepam in respiratory panic disorder 2004
Social phobia and panic disorder: responses to the carbon dioxide challenge test 2004
A Influência dos Traços de Personalidade sobre os Transtornos de Ansiedade e Depressão 2004
Ataques de pânico laboratoriais e eletroencefalograma quantitativo: um paradigma para uma amostra de transtorno de pãnico tratada com gabapentina 2004
Risk of recurrence of High Grade Cervical Intraepithelial Neoplasia (CIN) in HIV infected women treated by Large Loop Excision of the Transformation Zone (LLETZ) in Brazil 2001
Recorrência de Neoplasias Intraepiteliais Cervicais (NIC) em mulheres portadoras do HIV 2000
Recorrência de Neoplasias Intraepiteliais Cervicais (NIC) em Mulheres Portadoras do HIV 2000
Publicações:
Minha Rede: